Form 8-K - Current report:
SEC Accession No. 0001213900-25-052234
Filing Date
2025-06-06
Accepted
2025-06-06 17:20:10
Documents
13
Period of Report
2025-06-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0243953-8k_advanced.htm   iXBRL 8-K 25980
2 PURCHASE AGREEMENT ea024395301ex99-1_advanced.htm EX-99.1 205728
  Complete submission text file 0001213900-25-052234.txt   448877

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE advb-20250606.xsd EX-101.SCH 3023
4 XBRL LABEL FILE advb-20250606_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE advb-20250606_pre.xml EX-101.PRE 22364
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0243953-8k_advanced_htm.xml XML 3771
Mailing Address 401 RYLAND ST STE 200-A RENO NV 89502
Business Address 401 RYLAND ST STE 200-A RENO NV 89502 86-21-20510823
Advanced Biomed Inc. (Filer) CIK: 0001941029 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV
Type: 8-K | Act: 34 | File No.: 001-42548 | Film No.: 251032076
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)